- Home
- INDO vs AIDX Comparison
INDO vs AIDX Comparison
Compare INDO & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | AIDX |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Precision Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.4M | 58.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | INDO | AIDX |
|---|---|---|
| Price | $3.80 | $1.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.3M | 206.5K |
| Earning Date | 04-29-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.21 | $1.51 |
| 52 Week High | $8.50 | $14.09 |
Technical Indicators
Market Signals| Indicator | INDO | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 10.56 |
| Support Level | $2.72 | $1.60 |
| Resistance Level | $5.12 | $1.87 |
| Average True Range (ATR) | 0.37 | 0.28 |
| MACD | -0.10 | 0.22 |
| Stochastic Oscillator | 12.86 | 17.71 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.